Home
 /
Papers
 /
Bioinformatics
 /
Temporal AI model predicts drivers of cell state trajectories across human aging
Preprint
Open access
V1
Top 1% · Validated by QED

Temporal AI model predicts drivers of cell state trajectories across human aging

Javier Gόmez Ortega, Rangarajan D. Nadadur, Akira Kunitomi +22 more
April 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.03.30.715396
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Bioinformatics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Overturning the static-snapshot paradigm of single-cell AI, MaxToki learns cell-state trajectories across human aging and predicts experimentally verified pro-aging cardiac targets, making programmable control of therapeutic cellular trajectories an achievable goal.

QED claims analysis

Summary

MaxToki, a temporal AI model trained on nearly 1 trillion gene tokens across human aging trajectories, accurately predicts cell state progression over time through in-context learning of unseen trajectories and identifies novel age-modulating targets that were experimentally validated to cause age-related gene network dysregulation, functional decline in cardiomyocytes, and cardiovascular dysfunction in vivo.

See full analysis
Main Claim 1 –

MaxToki temporally generates past, intervening, and future cell states

Main Claim 2 –

MaxToki predicts timelapses for held-out ages and cell types

Supporting evidence

  • Generated cells preserve cell type identity and single-cell resolution
  • MaxToki captures non-monotonic gene dynamics in reprogramming inflection points
  • MaxToki attention prioritizes transcription factors and context-specific prompt features
Main Claim 3 –

In silico perturbations predict pro-aging versus rejuvenating cardiac targets

Supporting evidence

  • MaxToki infers disease-associated age acceleration in smoking, fibrosis, Alzheimer’s
  • ZBTB16 inhibition increases senescence in cardiac capillary endothelial cells
Main Claim 4 –

Pro-aging target overexpression impairs calcium handling in iPSC cardiomyocytes

Supporting evidence

  • P4HA1 and RASGEF1B induce senescence across cardiomyocytes and fibroblasts

Abstract

Foundational AI models have recently shown promise for predicting the impact of perturbations on cell states. However, current models typically consider only one cell state at a time, limiting their ability to learn how cellular responses unfold over time, particularly across long trajectories such as diseases of aging. Here, we develop a temporal AI model, MaxToki, trained on nearly 1 trillion gene tokens including cell state trajectories across the human lifespan to generate cell states across long timelapses of human aging. MaxToki generalized to unseen trajectories through in-context learning and predicted novel age-modulating targets that were experimentally verified to influence age-related gene programs and functional decline in vivo. MaxToki represents a promising strategy for temporal modeling to accelerate the discovery of interventions for programming therapeutic cellular trajectories.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?